EPHA2 and renal cell carcinoma: In all RCC cell lines, MET, EPHA2, PTK2 and SRC are among the top ranked active kinases (Figure 3B, Figure S3.1.1, Figure S3.1.2), while in EC-RF24 cells PTK2 and EPHA2 show a high ranking (Figure S3.1.3.